Acceso abierto

Analysis of the mitochondrial 4977 bp deletion in patients with hepatocellular carcinoma


Cite

Figure 1

Identification of the mtDNA 4977 bp deletion. M: DL2000 Marker; lane 1: control subjects without the 4977 bp deletion; lanes 2 and 3: patients with the mtDNA 4977 bp deletion.
Identification of the mtDNA 4977 bp deletion. M: DL2000 Marker; lane 1: control subjects without the 4977 bp deletion; lanes 2 and 3: patients with the mtDNA 4977 bp deletion.

Figure 2

Comparison of mtDNA content between HCC patients with the mtDNA 4977 bp deletion and control subjects.
Comparison of mtDNA content between HCC patients with the mtDNA 4977 bp deletion and control subjects.

Figure 3

Reactive oxygen species concentrations in HCC patients carrying the mtDNA 4977 bp deletion and control subjects.
Reactive oxygen species concentrations in HCC patients carrying the mtDNA 4977 bp deletion and control subjects.

Characterization of patients with hepatocellular carcinoma.

Parameters Number of HCC Patients mtDNA 4977 bp Deletion Frequency n (%)
Cases 104 10 (9.52)

Males 65 6 (5.71)
Females 40 4 (3.81)

Age ≥ 55 75 7 (6.67)
Age <55 30 3 (2.85)

History of alcohol consumption:
     yes 85 10 (9.52)
     no 20 0 (0.00)

Metastasis:
     positive 35 4 (3.81)
     negative 70 6 (5.71)
eISSN:
1311-0160
Idioma:
Inglés
Calendario de la edición:
2 veces al año
Temas de la revista:
Medicine, Basic Medical Science, other